Rising Rates of Cancer Worldwide
Cancer incidence is steadily increasing across ASEAN countries due to rapid urbanization, aging populations, and lifestyle changes such as higher tobacco use, sedentary behavior, and dietary shifts. Countries such as Indonesia, Thailand, Vietnam, and the Philippines are reporting rising cases of breast, colorectal, lung, and cervical cancers, while liver cancer remains highly prevalent in Vietnam and Thailand due to hepatitis infections. This growing cancer burden is driving greater demand for comprehensive treatment options, with radiation therapy playing a central role alongside surgery and systemic therapies.
Healthcare systems in ASEAN are improving cancer detection and referral networks, particularly in middle-income countries such as Malaysia, Thailand, and Vietnam. More patients are diagnosed at stages where radiation therapy is required either as a curative treatment or as adjuvant therapy. External beam radiation therapy is the most commonly used modality across the region due to its versatility and ability to treat a wide range of solid tumors, while brachytherapy is used for cervical and prostate cancers, especially in Thailand and Indonesia. This rising patient volume is placing pressure on public and private hospitals to expand radiation therapy capacity.
Governments across ASEAN are prioritizing oncology infrastructure as part of national cancer control programs. Investments in new cancer centers, linear accelerators, and regional referral hospitals are increasing, particularly in urban hubs such as Bangkok, Kuala Lumpur, and Jakarta. As cancer awareness campaigns and screening initiatives expand, especially for breast and cervical cancer, the number of patients requiring radiation therapy is expected to continue growing. This sustained increase in cancer prevalence remains a key driver for the ASEAN cancer radiation therapy market.
Growing Need for Tailored Medical Treatments
The ASEAN healthcare landscape is gradually shifting toward personalized medicine as clinicians and policymakers recognize the benefits of tailored cancer treatment. Personalized radiation therapy allows treatment plans to be customized based on tumor size, location, genetic characteristics, and patient-specific factors. This approach is important in ASEAN, where cancer presentation can vary widely due to genetic diversity and differences in environmental exposure. As a result, there is growing interest in advanced radiation techniques that improve precision and clinical outcomes.
Modern external beam radiation therapy technologies such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) are gaining adoption in more advanced ASEAN markets, including Singapore, Malaysia, and Thailand. These systems enable highly individualized dose planning and real-time tumor tracking, reducing damage to surrounding healthy tissue. In brachytherapy, personalized dose delivery is emphasized for cervical cancer, which remains one of the most common cancers among women in several ASEAN countries. This trend is encouraging hospitals to invest in sophisticated planning software and imaging capabilities.
Rising healthcare spending, medical tourism, and international collaborations are supporting the shift toward personalized cancer care in ASEAN. Singapore and Thailand, in particular, are positioning themselves as regional hubs for advanced oncology treatment, attracting patients from neighboring countries. As training programs for radiation oncologists and medical physicists expand, more centers are becoming capable of delivering customized radiation therapy protocols. This growing demand for personalized medicine represents a significant opportunity for technology providers and service companies in the ASEAN cancer radiation therapy market.
